{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:58:58Z","timestamp":1785513538285,"version":"3.56.0"},"reference-count":26,"publisher":"Mattioli1885","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction: Chronic spontaneous urticaria (CSU) and fibromyalgia (FM) share overlapping features such as autoimmunity, psychological influence, and female predominance. Previous studies show conflicting results on FM prevalence in CSU patients. Objectives: This study aimed to assess the prevalence of concurrent FM in patients with CSU. Methods: A cross-sectional study including 257 CSU patients and age- and sex-matched healthy controls. Data collected included demographics, disease duration, severity (UAS-7), and quality of life (DLQI). FM was diagnosed using the 2016 ACR criteria. Results: The prevalence of FM was 18.98% in CSU patients and 4.43% for the control group (P&lt;0.01). The mean WPI and SSS scores were higher in the CSU group; WPI was statistically significant (P &lt; 0.01), whereas SSS showed no statistically significant difference (P = 0.05). CSU patients with FM had longer disease duration, higher disease severity, and more impairment in life. Furthermore, female CSU patients had more FM than did male CSU patients (P&lt;0.001). Conclusions: FM was more prevalent among patients with CSU compared to the control group. Female sex, higher disease severity, and impaired quality of life were significantly associated with FM in CSU patients. Given the reduced quality of life observed in individuals with both conditions, clinicians should consider evaluating CSU patients, especially those with severe symptoms, for FM to ensure accurate diagnosis and comprehensive management. Further studies are needed to clarify the nature of this association.<\/jats:p>","DOI":"10.5826\/dpc.1603a6659","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:07:47Z","timestamp":1785510467000},"page":"6659","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Fibromyalgia Frequency in Chronic Spontaneous Urticaria Patients Referred to a Tertiary Dermatology Outpatient Clinic"],"prefix":"10.5826","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-3327","authenticated-orcid":false,"given":"Fatma","family":"Etg\u00fc","sequence":"first","affiliation":[{"name":"Ordu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-8032","authenticated-orcid":false,"given":"Derya","family":"C\u0131rakoglu","sequence":"first","affiliation":[{"name":"Ordu University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27750","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"10.5826\/dpc.1603a6659_ref1","doi-asserted-by":"crossref","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. DOI:10.1111\/all.15090","DOI":"10.1111\/all.15090"},{"key":"10.5826\/dpc.1603a6659_ref2","doi-asserted-by":"crossref","unstructured":"Mandel VD, Alicandro T, Pepe P, et al. Chronic spontaneous urticaria: a review of pathological mechanisms, diagnosis, clinical management, and treatment. EMJ. 2020;5(1):29-39. DOI:10.33590\/emj\/19-00162.","DOI":"10.33590\/emj\/19-00162"},{"key":"10.5826\/dpc.1603a6659_ref3","doi-asserted-by":"crossref","unstructured":"Mandel VD, Alicandro T, Pepe P, et al. Chronic spontaneous urticaria: a review of pathological mechanisms, diagnosis, clinical management, and treatment. EMJ. 2020;5(1):29-39. DOI:10.33590\/emj\/19-00162.","DOI":"10.33590\/emj\/19-00162"},{"key":"10.5826\/dpc.1603a6659_ref4","doi-asserted-by":"crossref","unstructured":"Manzoor H, Razi F, Rasheed A, et al. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis. Healthcare (Basel). 2022;10(12):2579. Published 2022 Dec 19. DOI:10.3390\/healthcare10122579","DOI":"10.3390\/healthcare10122579"},{"key":"10.5826\/dpc.1603a6659_ref5","doi-asserted-by":"crossref","unstructured":"Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270-1277. DOI:10.1016\/j.jaci.2014.02.036","DOI":"10.1016\/j.jaci.2014.02.036"},{"key":"10.5826\/dpc.1603a6659_ref6","doi-asserted-by":"crossref","unstructured":"Maurer M, Houghton K, Costa C, et al. Differences in chronic spontaneous urticaria between Europe and Central\/South America: results of the multi-center real world AWARE study. World Allergy Organ J. 2018;11(1):32. Published 2018 Nov 16. DOI:10.1186\/s40413-018-0216-1","DOI":"10.1186\/s40413-018-0216-1"},{"key":"10.5826\/dpc.1603a6659_ref7","doi-asserted-by":"crossref","unstructured":"Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA\u00b2LEN task force report. Allergy. 2011;66(3):317-330. DOI:10.1111\/j.1398-9995.2010.02496.x","DOI":"10.1111\/j.1398-9995.2010.02496.x"},{"key":"10.5826\/dpc.1603a6659_ref8","doi-asserted-by":"crossref","unstructured":"Kalkan F, Ye\u015fillik S, Demirel F, et al. Comparison of long term efficacy and cost-effectiveness of omalizumab in 150 mg and 300 mg doses in patients with chronic spontaneous urticaria. An Bras Dermatol. 2025;100(1):31-37. DOI:10.1016\/j.abd.2024.02.006","DOI":"10.1016\/j.abd.2024.02.006"},{"key":"10.5826\/dpc.1603a6659_ref9","doi-asserted-by":"crossref","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-329. DOI:10.1016\/j.semarthrit.2016.08.012","DOI":"10.1016\/j.semarthrit.2016.08.012"},{"key":"10.5826\/dpc.1603a6659_ref10","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Dom\u00ednguez M. A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System. Biomedicines. 2025;13(1):165. Published 2025 Jan 11. DOI:10.3390\/biomedicines13010165","DOI":"10.3390\/biomedicines13010165"},{"key":"10.5826\/dpc.1603a6659_ref11","doi-asserted-by":"crossref","unstructured":"Erdrich S, Harnett JE. Fibromyalgia severity and symptoms are associated with the disorders of gut-brain interaction. Eur J Pain. 2025;29(1):10.1002\/ejp.4766. DOI:10.1002\/ejp.4766","DOI":"10.1002\/ejp.4766"},{"key":"10.5826\/dpc.1603a6659_ref12","doi-asserted-by":"crossref","unstructured":"Rubio-Zarapuz A, Parraca JA, Tornero-Aguilera JF, Clemente-Su\u00e1rez VJ. Unveiling the link: exploring muscle oxygen saturation in fibromyalgia and its implications for symptomatology and therapeutic strategies. Med Gas Res. 2025;15(1):58-72. DOI:10.4103\/mgr.MEDGASRES-D-24-00013","DOI":"10.4103\/mgr.MEDGASRES-D-24-00013"},{"key":"10.5826\/dpc.1603a6659_ref13","doi-asserted-by":"crossref","unstructured":"D'Onghia M, Ciaffi J, Calabrese L, et al. Fibromyalgia and Skin Disorders: A Systematic Review. J Clin Med. 2024;13(15):4404. Published 2024 Jul 27. DOI:10.3390\/jcm13154404","DOI":"10.3390\/jcm13154404"},{"key":"10.5826\/dpc.1603a6659_ref14","doi-asserted-by":"crossref","unstructured":"Hawro T, Ohanyan T, Schoepke N, et al. The Urticaria Activity Score-Validity, Reliability, and Responsiveness. J Allergy Clin Immunol Pract. 2018;6(4):1185-1190.e1. DOI:10.1016\/j.jaip.2017.10.001","DOI":"10.1016\/j.jaip.2017.10.001"},{"key":"10.5826\/dpc.1603a6659_ref15","unstructured":"Finlay AY. Quality of life indices. Indian J Dermatol Venereol Leprol. 2004;70(3):143-148."},{"key":"10.5826\/dpc.1603a6659_ref16","doi-asserted-by":"crossref","unstructured":"Ozt\u00fcrkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45(11):1300-1307. DOI:10.1111\/j.1365-4632.2006.02881.x","DOI":"10.1111\/j.1365-4632.2006.02881.x"},{"key":"10.5826\/dpc.1603a6659_ref17","doi-asserted-by":"crossref","unstructured":"Yener M, Erturan I, Ceyhan AM, Inal EE, Kazanoglu OO. The evaluation of prevalence of fibromyalgia in patients with chronic urticaria. Med Sci Monit. 2013;19:757-761. Published 2013 Sep 11. DOI:10.12659\/msm.889626","DOI":"10.12659\/MSM.889626"},{"key":"10.5826\/dpc.1603a6659_ref18","doi-asserted-by":"crossref","unstructured":"G\u00f6z\u00fcb\u00fcy\u00fcko\u011fullar\u0131 A, Onan DT, All\u0131 N. Fibromyalgia syndrome in chronic urticaria patients. Turkderm. 2014;48(4):215-218. DOI:10.4274\/turkderm.48902.","DOI":"10.4274\/turkderm.48902"},{"key":"10.5826\/dpc.1603a6659_ref19","doi-asserted-by":"crossref","unstructured":"Hapa A, Ozdemir O, Ersoy-Evans S, Atakan N, Inanici F. Evaluation of the frequency of fibromyalgia in patients with chronic urticaria. Turkderm. 2012;46(4):202-205. DOI:10.4274\/Turkderm.81489.","DOI":"10.4274\/Turkderm.81489"},{"key":"10.5826\/dpc.1603a6659_ref20","doi-asserted-by":"crossref","unstructured":"Oktayoglu P, Ucmak D, Caglayan M, et al. Is there an association between chronic urticaria and fibromyalgia syndrome? Arch Rheumatol. 2014;29(1):28-34. DOI:10.5606\/tjr.2014.3550.","DOI":"10.5606\/tjr.2014.3550"},{"key":"10.5826\/dpc.1603a6659_ref21","doi-asserted-by":"crossref","unstructured":"Mathkhor AJ, Mohammed JQ. Prevalence of fibromyalgia syndrome in chronic urticaria. Middle East J Fam Med. 2020;18(10):102-106. DOI:10.5742\/MEWFM.2020.93897.","DOI":"10.5742\/MEWFM.2020.93853"},{"key":"10.5826\/dpc.1603a6659_ref22","doi-asserted-by":"crossref","unstructured":"Acar EM, \u015ea\u015f S. Evaluation of fibromyalgia frequency in chronic urticaria patients and its association with urticaria severity. Ahi Evran Med J. 2022;6(3):276-281. DOI:10.46332\/aemj.975877.","DOI":"10.46332\/aemj.975877"},{"key":"10.5826\/dpc.1603a6659_ref23","doi-asserted-by":"crossref","unstructured":"Koca TT, Nazik H, M\u00fclayim MK, \u00d6zt\u00fcrk P. The relation of chronic idiopathic urticaria with fibromyalgia, sleep disturbance and anxiety. J Contemp Med. 2019;9(2):151-155. DOI:10.16899\/jcm.578711.","DOI":"10.16899\/jcm.578711"},{"key":"10.5826\/dpc.1603a6659_ref24","doi-asserted-by":"crossref","unstructured":"Torresani C, Bellafiore S, De Panfilis G. Chronic urticaria is usually associated with fibromyalgia syndrome. Acta Derm Venereol. 2009;89(4):389-392. DOI:10.2340\/00015555-0653","DOI":"10.2340\/00015555-0653"},{"key":"10.5826\/dpc.1603a6659_ref25","doi-asserted-by":"crossref","unstructured":"Erdogan HK, \u015ea\u015f S, Acar E, Bulur I, Altunay IK, Erdem HR. Cutaneous findings in fibromyalgia syndrome and their effect on quality of life. Dermatol Sin. 2016;34(3):131-134. DOI:10.1016\/j.dsi.2016.04.002.","DOI":"10.1016\/j.dsi.2016.01.006"},{"key":"10.5826\/dpc.1603a6659_ref26","doi-asserted-by":"crossref","unstructured":"Coskun Benlidayi I. Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int. 2019;39(5):781-791. DOI:10.1007\/s00296-019-04251-6","DOI":"10.1007\/s00296-019-04251-6"}],"container-title":["Dermatology Practical &amp; Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/6659\/3882","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/6659\/3882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:07:53Z","timestamp":1785510473000},"score":1,"resource":{"primary":{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/view\/6659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1603a6659","relation":{"has-manifestation":[{"id-type":"other","id":"1-84-6659-g3882","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.1603a%a","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"value":"2160-9381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"12"}}